BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ARMI - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.armiusa.org
X-WR-CALDESC:Events for ARMI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20280312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20281105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20280312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20281105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261202
DTEND;VALUE=DATE:20261204
DTSTAMP:20261030T141401Z
CREATED:20261030T141401Z
LAST-MODIFIED:20261030T141401Z
UID:10001817-1796169600-1796342399@www.armiusa.org
SUMMARY:NIH-HESI Workshop: Assessing Emerging Cell and Gene Therapies for Disease-Specific Therapeutic Applications
DESCRIPTION:ARMI | BioFabUSA will participate in the upcoming National Institutes of Health (NIH) and Health and Environmental Sciences Institute (HESI) workshop\, Assessing Emerging Cell and Gene Therapies for Disease-Specific Therapeutic Applications: In Vivo Tracking and Biodistribution. \nDr. Richard McFarland\, ARMI’s Chief Regulatory Officer\, will serve as a panel moderator\, contributing to discussions focused on advancing scientific understanding\, cross-sector collaboration\, and the development of cell and gene therapies. \nThis two-day workshop brings together experts from government\, academia\, industry\, and other stakeholder organizations to examine the current state of in vivo tracking and biodistribution technologies across preclinical and clinical applications. \nWorkshop Highlights\nTopics will include: \n\nCurrent approaches to tracking the localization\, persistence\, and fate of cell and gene therapies.\nTechnical challenges and emerging imaging technologies.\nRegulatory and public health considerations.\nOpportunities to strengthen translation from preclinical research to clinical applications.\nFuture research priorities\, funding opportunities\, and industry-government-academic collaboration.\n\nThe workshop will feature presentations\, panel discussions\, and breakout sessions designed to identify scientific and technical gaps and opportunities to advance cell and gene therapy development. \nRegistration: Learn More & Register \nOrganizer: National Institutes of Health (NIH) and Health and Environmental Sciences Institute (HESI Global).
URL:https://www.armiusa.org/event/nih-hesi-workshop-assessing-emerging-cell-and-gene-therapies-for-disease-specific-therapeutic-applications/
LOCATION:Hybrid
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20270111T070000
DTEND;TZID=America/Los_Angeles:20270114T180000
DTSTAMP:20261117T195948Z
CREATED:20261117T195748Z
LAST-MODIFIED:20261117T195948Z
UID:10001818-1799650800-1799949600@www.armiusa.org
SUMMARY:JPM Week 2027 | Connect with ARMI in San Francisco
DESCRIPTION:ARMI | BioFabUSA will be participating in JPM Week 2027\, joining industry leaders\, investors\, innovators\, and strategic partners for conversations focused on the future of advanced biomanufacturing and the commercialization of next-generation biotherapeutics. Throughout the week\, members of the ARMI team will be connecting with organizations interested in advancing manufacturing technologies\, scaling innovative therapies\, and exploring opportunities for collaboration. \nPlanning to be in San Francisco?\nWe welcome the opportunity to connect with industry colleagues\, current and prospective partners\, and organizations interested in learning more about ARMI | BioFabUSA. To inquire about meeting with our team during JPM Week\, please contact events@armiusa.org.
URL:https://www.armiusa.org/event/jpm-week-2027-connect-with-armi-in-san-francisco/
LOCATION:San Francisco\, CA\, United States
CATEGORIES:ARMI,BioFabUSA
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270118
DTEND;VALUE=DATE:20270122
DTSTAMP:20261029T131025Z
CREATED:20261029T131025Z
LAST-MODIFIED:20261029T131025Z
UID:10001816-1800230400-1800575999@www.armiusa.org
SUMMARY:Advanced Therapies Week 2027
DESCRIPTION:ARMI | BioFabUSA is pleased to partner with Phacilitate for Advanced Therapies Week 2027\, a leading industry gathering bringing together innovators\, manufacturers\, investors\, and technology developers working to advance cell and gene therapies and next-generation biotherapeutics. \nThe four-day event provides opportunities to explore emerging technologies\, manufacturing challenges\, commercialization strategies\, and the partnerships needed to move advanced therapies toward clinical and commercial applications. \nARMI | BioFabUSA Participation\nAs part of its collaboration with Phacilitate\, ARMI will contribute to programming focused on supporting emerging companies and advancing manufacturing readiness. \nARMI’s involvement includes the Founders Forum on January 18\, where discussions will explore considerations for companies navigating the transition from early-stage innovation toward scalable manufacturing and commercialization. \nTopics are expected to include:\n\nManufacturing readiness and scale-up strategies\nClinical development and CMC considerations\nQuality and regulatory planning\nFinancing and commercialization pathways\nPartnerships and manufacturing infrastructure for emerging companies\n\nAdditional details regarding ARMI participation and speakers will be announced as programming is finalized. \nARMI | BioFabUSA Member Opportunities\nAs an event partner\, ARMI | BioFabUSA is pleased to help connect our members with opportunities to participate in Advanced Therapies Week 2027. \nBioFabUSA members interested in attending are encouraged to contact our team at outreach_membership@armiusa.org to learn more about available registration benefits and opportunities to engage with the ARMI community during the event. \nLearn More & Register: Advanced Therapies Week 2027
URL:https://www.armiusa.org/event/advanced-therapies-week-2027/
LOCATION:San Diego\, CA\, CA\, United States
CATEGORIES:ARMI,BioFabUSA,Partner Event
ATTACH;FMTTYPE=image/png:https://www.armiusa.org/wp-content/uploads/2022/05/PartnerLive-e1653358779467.png
END:VEVENT
END:VCALENDAR